HEALTH GAINS AND FINANCIAL PROTECTION FROM PNEUMOCOCCAL VACCINATION AND PNEUMONIA TREATMENT IN ETHIOPIA: RESULTS FROM AN EXTENDED COST-EFFECTIVENESS ANALYSIS.

BACKGROUND:Pneumonia and pneumococcal disease cause a large disease burden in resource-constrained settings.We pursue an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-five children in Ethiopia.METHODS:We apply ECEA methods

Since 1991, a nationwide histopathology and cytopathology network and archive is in operation in The Netherlands under the name PALGA, encompassing all sixty-four pathology laboratories in The Netherlands.The overall system comprises decentralized systems at the participating laboratories, a central databank, and a dedicated communication and infor

IntroductionIn 2020, the Directorate General of Health (DGS), a central service of the Ministry of Health in Portugal, approved and co-financed the first Open Dialogue program in the country.The present report aims to demonstrate the preliminary results of the first year of the project, implemented in the northern interior region of Alentejo.Method